These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 21061174)

  • 1. Care for patients with multiple endocrine neoplasia type 1: the current evidence base.
    Pieterman CR; Vriens MR; Dreijerink KM; van der Luijt RB; Valk GD
    Fam Cancer; 2011 Mar; 10(1):157-71. PubMed ID: 21061174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical aspects of multiple endocrine neoplasia type 1.
    Al-Salameh A; Cadiot G; Calender A; Goudet P; Chanson P
    Nat Rev Endocrinol; 2021 Apr; 17(4):207-224. PubMed ID: 33564173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple endocrine neoplasia type 1.
    Marini F; Falchetti A; Del Monte F; Carbonell Sala S; Gozzini A; Luzi E; Brandi ML
    Orphanet J Rare Dis; 2006 Oct; 1():38. PubMed ID: 17014705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New therapies for patients with multiple endocrine neoplasia type 1.
    Geslot A; Vialon M; Caron P; Grunenwald S; Vezzosi D
    Ann Endocrinol (Paris); 2021 Apr; 82(2):112-120. PubMed ID: 33839123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multiple endocrine neoplasia type 1].
    Salmela PI
    Duodecim; 2012; 128(22):2345-54. PubMed ID: 23342481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the appropriate management of nonfunctioning pancreatic neuroendocrine tumours disclosed on screening in adult patients with multiple endocrine neoplasia type 1?
    Challis BG; Casey RT; Grossman A; Newell-Price J; Newey P; Thakker RV
    Clin Endocrinol (Oxf); 2019 Dec; 91(6):708-715. PubMed ID: 31505044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple endocrine neoplasia type 1: extensive analysis of a large database of Florentine patients.
    Marini F; Giusti F; Brandi ML
    Orphanet J Rare Dis; 2018 Nov; 13(1):205. PubMed ID: 30428914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).
    Gaztambide S; Vazquez F; Castaño L
    Minerva Endocrinol; 2013 Mar; 38(1):17-28. PubMed ID: 23435440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial parathyroid tumours-comparison of clinical profiles between syndromes.
    Figueiredo AA; Saramago A; Cavaco BM; Simões-Pereira J; Leite V
    J Endocrinol Invest; 2023 Sep; 46(9):1799-1806. PubMed ID: 36780067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
    Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS
    Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical clinical manifestations of multiple endocrine neoplasia type 1 syndrome.
    Krysiak R; Kajdaniuk D; Marek B; Okopień B
    Pol Arch Med Wewn; 2009 Mar; 119(3):175-9. PubMed ID: 19514648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors.
    de Laat JM; Tham E; Pieterman CR; Vriens MR; Dorresteijn JA; Bots ML; Nordenskjöld M; van der Luijt RB; Valk GD
    Eur J Endocrinol; 2012 Aug; 167(2):181-7. PubMed ID: 22581216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers.
    Machens A; Schaaf L; Karges W; Frank-Raue K; Bartsch DK; Rothmund M; Schneyer U; Goretzki P; Raue F; Dralle H
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):613-22. PubMed ID: 17590169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple Endocrine Neoplasia Type 1: The Potential Role of microRNAs in the Management of the Syndrome.
    Donati S; Ciuffi S; Marini F; Palmini G; Miglietta F; Aurilia C; Brandi ML
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the clinical management of multiple endocrine neoplasia type 1.
    Pieterman CRC; Valk GD
    Clin Endocrinol (Oxf); 2022 Oct; 97(4):409-423. PubMed ID: 35319130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
    Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct Prognostic Factors in Sporadic and Multiple Endocrine Neoplasia Type 1-Related Pancreatic Neuroendocrine Tumors.
    Kfir SK; Halperin R; Percik R; Uri I; Halpern N; Shlomai G; Laish I; Tirosh A; Tirosh A
    Horm Metab Res; 2021 May; 53(5):319-325. PubMed ID: 33878789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges and controversies in management of pancreatic neuroendocrine tumours in patients with MEN1.
    Yates CJ; Newey PJ; Thakker RV
    Lancet Diabetes Endocrinol; 2015 Nov; 3(11):895-905. PubMed ID: 26165399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multiple Endocrine Neoplasia I (Wermers Syndrome), Forms of Clinical Manifestation, 5 Case Studies].
    Drbalová K; Herdová K; Krejčí P; Nývltová M; Solař S; Vedralová L; Záruba P; Netuka D; Bavor P
    Vnitr Lek; 2016; 62(9 Suppl 3):140-149. PubMed ID: 27734708
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.